78 related articles for article (PubMed ID: 15226776)
1. Performance of the UroVysion
Rosolen DCB; Faria DK; Faria CS; Antonangelo L
Cancer Med; 2018 May; 7(5):1967-1977. PubMed ID: 29577646
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer tumor markers in serous effusions and other body fluids.
Trapé J; Bérgamo S; González-Garcia L; González-Fernández C
Tumour Biol; 2024; 46(s1):S99-S110. PubMed ID: 36502355
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Study of 117 Body Fluids: Comparison of Conventional Smear and Cell Block Technique.
Kumar SH; S S; Shetty D; Rao R
Curr Health Sci J; 2020; 46(4):336-343. PubMed ID: 33717507
[TBL] [Abstract][Full Text] [Related]
4. Self-Renewal Inhibition in Breast Cancer Stem Cells: Moonlight Role of PEDF in Breast Cancer.
Gil-Gas C; Sánchez-Díez M; Honrubia-Gómez P; Sánchez-Sánchez JL; Alvarez-Simón CB; Sabater S; Sánchez-Sánchez F; Ramírez-Castillejo C
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001682
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry, molecular analysis, and other special techniques (in Serous Fluid Cytopathology).
Gabali A
Cytojournal; 2022; 19():18. PubMed ID: 35510118
[TBL] [Abstract][Full Text] [Related]
6. Detection of carcinoma in serous effusions: a review.
Li M; Zhao L; Zhou X; Zhang K; Yin P; Liu S; Zou Y; Li Q
Am J Cancer Res; 2021; 11(1):43-60. PubMed ID: 33520359
[TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor Cells Counting Act as a Potential Prognostic Factor in Cervical Cancer.
Du K; Huang Q; Bu J; Zhou J; Huang Z; Li J
Technol Cancer Res Treat; 2020; 19():1533033820957005. PubMed ID: 33034270
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic impact of ascites cytology in 941 patients: malignancy rates and time of detection in ovarian cancer relative to other tumor types.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Vieth M; Rösch S; Lermann J
Arch Gynecol Obstet; 2020 Jun; 301(6):1521-1532. PubMed ID: 32347356
[TBL] [Abstract][Full Text] [Related]
9. Effusion cytomorphology of small round cell tumors.
Ikeda K; Tsuta K
J Cytol; 2016; 33(2):85-92. PubMed ID: 27279684
[TBL] [Abstract][Full Text] [Related]
10. CEP3 and CEP17 DNA probe potential in the genetic diagnosis and prognostic prediction of esophageal squamous cell cancer.
Niyaz M; Abdurahman A; Turghun A; Awut I
Exp Ther Med; 2016 Apr; 11(4):1375-1380. PubMed ID: 27073452
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathological diagnosis for early esophageal cancer in Kazakh patients.
Awut I; Niyaz M; Biekemitoufu H; Zhang Z; Sheyhedin I; Hao W
Oncol Lett; 2012 Mar; 3(3):549-553. PubMed ID: 22740949
[TBL] [Abstract][Full Text] [Related]
12. Use of discard pleural fluid in molecular research.
Grannis FW
Nat Rev Clin Oncol; 2011 Dec; 9(1):64; author reply 64. PubMed ID: 22158120
[No Abstract] [Full Text] [Related]
13. Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.
Neragi-Miandoab S
Support Care Cancer; 2008 Dec; 16(12):1323-31. PubMed ID: 18259780
[TBL] [Abstract][Full Text] [Related]
14. Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).
Fiegl M; Massoner A; Haun M; Sturm W; Kaufmann H; Hack R; Krugmann J; Fritzer-Szekeres M; Grünewald K; Gastl G
Br J Cancer; 2004 Aug; 91(3):558-63. PubMed ID: 15226776
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
[TBL] [Abstract][Full Text] [Related]
16. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma.
Fiegl M; Kaufmann H; Zojer N; Schuster R; Wiener H; Müllauer L; Roka S; Huber H; Drach J
Hum Pathol; 2000 Apr; 31(4):448-55. PubMed ID: 10821492
[TBL] [Abstract][Full Text] [Related]
17. Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients.
Zojer N; Fiegl M; Angerler J; Müllauer L; Gsur A; Roka S; Pecherstorfer M; Huber H; Drach J
Br J Cancer; 1997; 75(3):403-7. PubMed ID: 9020486
[TBL] [Abstract][Full Text] [Related]
18. The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion.
Fiegl M
Curr Opin Pulm Med; 2005 Jul; 11(4):313-8. PubMed ID: 15928498
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
